Quince Therapeutics Statistics
NASDAQ: QNCXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
29.36+2.64 (+9.88%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Quince Therapeutics by the numbers
Quince Therapeutics has a market capitalization of $29.9 million based on 1.02M shares outstanding. With trailing EPS of $-214.01, Quince Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.4% below its 50-day average and 72.2% below its 200-day average.
Average daily trading volume is 28.49K shares, or about $836,554 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
QNCX valuation vs. peer median
| Metric | QNCX | Peer median | Difference |
|---|---|---|---|
| Market cap | $29.86M | $26.28M | +14% |
| Avg. volume | 28.49K | 145.47K | -80% |
Peer median across 8 companies: EVAX, ATYR, ALGS, SCLX, GNTA, CVM, JSPR, ESLA.
Valuation
- Market cap
- $29.86M
- EPS (TTM)
- $-214.01
- Shares outstanding
- 1.02M
Price and trading
- Previous close
- 26.72
- Open
- 27.10
- Day range
- 26.84 – 29.80
- 52-week range
- 15.10 – 910.00
- 52-week change
- -92.49%
- 200-day moving average
- 105.71
- Beta
- —
- Volume
- 31.84K
- Average volume
- 28.49K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2026
Additional statistics
- Market Cap
- 29.86M
- Forward Pe
- -6.27
- Eps
- -214.01
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 910.00
- Week52 Low
- 15.10
- Avg Volume
- 28,493.00
- Shares Outstanding
- 1.02M
- Ma50
- 30.09
- Ma200
- 105.71
- Earnings Date
- Aug 14, 2026
- Pct From52w High
- -96.77%
- Pct From52w Low
- 94.44%